IMV Inc. Made Big Gain
Thu, Dec 15, 2022 at 06:58 PM
IMV Inc. (IMV:NASDAQ) shot up at $3.64, a gain of 66.6%. On Thu, Dec 15, 2022, IMV:NASDAQ touched a New 2-Week High of $3.64. The stock appeared on our News Catalysts scanner on Thu, Dec 15, 2022 at 08:04 AM in the 'BIOTECH' category. From Thu, Dec 01, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About IMV Inc. (IMV:NASDAQ)
Immunovaccine Inc is a Canada based clinical-stage biopharmaceutical company. Through its subsidiary, the firm develops T cell activating cancer immunotherapies and infectious disease vaccines based on DepoVax.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Core Scientific Inc Cl A (CORZ:NASDAQ), 72%
- IMV Inc. (IMV:NASDAQ), 66.55%
- Creatd Inc. (CRTD:NASDAQ), 57.76%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 44.85%
- BeyondSpring Inc. (BYSI:NASDAQ), 33.04%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 31.13%
- Nuvve Holding Corp. (NVVE:NASDAQ), 31.05%
- Landos Biopharma Inc. (LABP:NASDAQ), 30.46%
- NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ), 27.66%